Challenge

The Sponsor needed to find a way of dealing with unsolicited patient requests for its phase 2 study drug.

Challenge

The Sponsor needed to find a cost- and time-effective alternative to an OLEX study for providing access to the study drug, post-phase 3 clinical trials.

NEED MORE INFORMATION?